ReviewKidney medicine2025
Examining Inequities in Clinical Outcomes for Indigenous Patients Treated With Dialysis in Canada: A Scoping Review.
Review in Kidney medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Geographical Information Systems-Based Wildfire Risk Analysis of Canadian Dialysis Facilities.Kidney international reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The burden of kidney disease among Indigenous peoples in Canada is disproportionately higher than the rest of the population. We aimed to synthesize the existing knowledge on the clinical outcomes among Indigenous peoples treated with dialysis in Canada. We searched MEDLINE, Embase, CINAHL, Scopus, Web of Science Core Collection, and the Bibliography of Indigenous Peoples of North America, supplemented by a gray literature review. The following inclusion criteria were used: (1) studies assessing dialysis patients, (2) including Canadian Indigenous patients, and (3) relating to incidence, mortality, treatment complications, access to care, and/or quality of life. Forty-four studies, conducted across multiple Canadian provinces, were included. Fifteen studies highlighted the higher prevalence of diabetic and nondiabetic kidney failure among Indigenous Canadians compared with non-Indigenous Canadians. Indigenous patients experienced more frequent dialysis-related infections and cardiovascular complications, increased hospitalization rates, lower rates of arteriovenous fistula creation, lower use of home dialysis, reduced access to health care services, and decreased quality of life because of relocation for dialysis. Few studies explored the underlying causes of the observed inequities. Our findings underscore the need to better understand the contributing factors to develop culturally appropriate interventions, codesigned with Indigenous communities, that promote equitable care for Indigenous patients receiving dialysis.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.